ALS stem cell trial begins at U-M Health System with first two patients … – Medical Xpress
| Medical Xpress The Phase II trial is approved by the U.S. Food and Drug Administration and funded by Neuralstem, Inc., the Maryland-based company whose stem-cell product the trial is testing. It seeks to study any effect that injected stem cells might have on motor … University Of Michigan Health System Treats Its First Patients In Neuralstem’s …PR Newswire (press release) |
